Menu

Is ketamine about to become inaccessible in low-income countries?

by

A storm is brewing with the potential to create a global “public health crisis”, denying access to safe surgery and anesthesia for roughly a billion people in low-income countries.  The issue at stake? Access to ketamine, the anesthetic of necessity in most low-income countries. The Commission on Narcotic Drugs, the central drug policy-making body within […]

Read More

Canadians are paying too much for generic drugs

by

I am the co-author of a publication in Open Medicine today that’s getting quite a bit of media coverage. Our study “Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines” was published this morning online, and has since been covered by The Toronto Star and in various publications by the Canadian […]

Read More

Health system indicators everywhere! Will we know success when we see it?

by

I am attending the Third Global Symposium on Health Systems Research in Cape Town this week. The central focus and theme of the conference this year is on people-centered health systems, putting patients, their families, and communities at the center of everything that we do. Intersecting this goal is, of course, a need to measure […]

Read More